IMPACT OF FACTOR VIII GENE (F8) MUTATION ON IMMUNE TOLERANCE INDUCTION (ITI) OUTCOMES IN HAEMOPHILIA A PATIENTS WITH INHIBITORS IN THE OBSITI STUDY

被引：0
|
作者：
Pavlova, A. [1 ]
Escuriola-Ettingshausen, C. [2 ]
Oldenburg, J. [1 ]
机构：
[1] Univ Clin Bonn, Inst Expt Haematol & Transfus Med, Bonn, Germany
[2] HZRM Hamophilie Zentrum Rhein Main GmbH, Morfelden Walldorf, Germany
来源：
HAEMOPHILIA | 2020年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P055
引用
收藏
页码：54 / 54
页数：1
相关论文
共 50 条
  • [31] SURVEY AND UPDATE ON THE PRACTICE OF IMMUNE TOLERANCE INDUCTION IN PATIENTS WITH HAEMOPHILIA A AND FACTOR VIII INHIBITORS ACROSS EAST MEDITERRANEAN REGION
    Elalfy, M.
    Eltonbary, K.
    Elalfy, O.
    Gouider, E.
    Elekiaby, M.
    HAEMOPHILIA, 2023, 29 : 69 - 69
  • [32] Characterization of a causative mutation of hemophilia A identified in the promoter region of the factor VIII gene (F8)
    Dai, L.
    Cutler, J. A.
    Savidge, G. F.
    Mitchell, M. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (01) : 193 - 195
  • [33] Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors (vol 136, pg 12, 2007)
    Reipert, B. M.
    Van Helden, P. M. W.
    Schwarz, H. P.
    Hausl, C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (02) : 350 - 350
  • [34] A role for von Willebrand factor in immune tolerance induction in patients with haemophilia A and inhibitors?
    Di Minno, Giovanni
    Coppola, Antonio
    BLOOD TRANSFUSION, 2011, 9 : S14 - S20
  • [35] Factor VIII gene (F8) mutation and inhibitor development in non-severe hemophilia A
    De Groot-Eckhardt, C. L.
    Van Velzen, A. S.
    Peters, M.
    Peerlinck, K.
    Oldenburg, J.
    Santagostino, E.
    Astermark, J.
    Van Heerde, W. L.
    Hermans, C.
    Morfini, M.
    Castaman, G.
    Haya, S.
    McRae, S.
    Reitter-Pfoertner, S. E.
    Kamphuisen, P. W.
    Van der Bom, J. G.
    Fijnvandraat, K. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 33 - 33
  • [36] F8 gene mutations and ITT response in the Italian cohort of haemophilia A patients with inhibitors.
    Tagariello, G
    Salviato, R
    Belvini, D
    Radossi, P
    Zanon, E
    Gandini, G
    Castaman, G
    Sartori, R
    BLOOD, 2005, 106 (11) : 897A - 897A
  • [37] Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors-A retrospective analysis
    Carcao, M.
    Shapiro, A.
    Staber, J. M.
    Hwang, N.
    Druzgal, C.
    Lieuw, K.
    Belletrutti, M.
    Thornburg, C. D.
    Ahuja, S. P.
    Morales-Arias, J.
    Dumont, J.
    Miyasato, G.
    Tsao, E.
    Jain, N.
    Pipe, S. W.
    HAEMOPHILIA, 2018, 24 (02) : 245 - 252
  • [38] Immune tolerance therapy utilizing factor VIII/von Willebrand factor concentrate in haemophilia A patients with high titre factor VIII inhibitors
    Kurth, M. A. H.
    Dimichele, D.
    Sexauer, C.
    Sanders, J. M.
    Torres, M.
    Zappa, S. C.
    Ragni, M.
    Leonard, N.
    HAEMOPHILIA, 2008, 14 (01) : 50 - 55
  • [39] Immune Tolerance Induction (ITI) in Paediatric and Adult Patients with Haemophilia a (HA) and High-Titre (HT) Factor VIII (FVIII) Inhibitor - Real Life Data
    Letowska, Magdalena Katarzyna
    Zawilska, Krystyna
    Klukowska, Anna
    Chojnowski, Krzysztof
    Zdziarska, Joanna
    Stefanska-Windyga, Ewa
    Windyga, Jerzy
    BLOOD, 2019, 134
  • [40] COSTS AND OUTCOMES OF PATIENTS WITH HAEMOPHILIA A (HA) AND FACTOR VIII INHIBITORS TREATMENT: THE IMMUNE TOLERANCE AND ECONOMICS RETROSPECTIVE REGISTRY (ITER) RESULTS
    Gringeri, A.
    Scalone, L.
    Cortesi, P. A.
    Rocino, A.
    Mantovani, L. G.
    VALUE IN HEALTH, 2012, 15 (04) : A103 - A103
12345